TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35651925

Group type: EXPERIMENTAL
Intervention: AI limb rehabilitation system on account of VR technology
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional drug therapy
Number of subjects: 50
Study: 33707105

Group type: EXPERIMENTAL
Intervention: Blue light blocking (BLB) glasses
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (clear lens) glasses
Number of subjects: 20
Study: 32379974

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model for predicting relative response factors (RRFs) using CE-MS ESI+ data set
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model for predicting RRFs using LC-QTOF/MS ESI+ data set
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model for predicting RRFs using LC-QTOF/MS ESI- data set
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) model for predicting RRFs; specific outcomes not detailed in the abstract
Number of subjects: 0
Study: 33620614

Group type: EXPERIMENTAL
Intervention: Quality of life assessed with WHOQOL-BREF (psychological domain)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Quality of life assessed with WHOQOL-BREF (social relationships domain)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Quality of life assessed with WHOQOL-BREF (physical health domain)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Quality of life assessed with WHOQOL-BREF (environment domain)
Number of subjects: 479
Study: 32222613

Group type: COMPARATOR
Intervention: Excluded participants
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Included participants
Number of subjects: 130
Study: 36345922

Group type: EXPERIMENTAL
Intervention: Durapore (DP)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Hy-Tape (HT)
Number of subjects: 112
Study: 32032096

Group type: EXPERIMENTAL
Intervention: Electroencephalogram-guided anesthesia
Number of subjects: 1113

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: Electroencephalogram suppression
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: Preoperative abnormal cognition
Number of subjects: 1113
Study: 33883615

Group type: EXPERIMENTAL
Intervention: Aptamer Apt1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aptamer Apt2
Number of subjects: 0
Study: 36232045

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 12
Study: 33799119

Group type: EXPERIMENTAL
Intervention: Virtual Reality warm-up before surgery
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Running Suture task on the simulator
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no warm-up)
Number of subjects: 34
Study: 32336153

Group type: EXPERIMENTAL
Intervention: DASH diet adherence (highest quartile)
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: DASH diet adherence (highest quartile) in postmenopausal women
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: DASH diet adherence (highest quartile) in premenopausal women
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: DASH diet adherence (highest quartile) among normal-weight women
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: DASH diet adherence (highest quartile) among obese women
Number of subjects: 1050
Study: 35987093

Group type: EXPERIMENTAL
Intervention: Comprehensive Behavioral Intervention for Tics (CBIT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: EEG coherence during a Go/NoGo task
Number of subjects: 32
Study: 33794122

Group type: COMPARATOR
Intervention: Surrogates of patients living at home
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Surrogates of patients readmitted to an acute care hospital
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Surrogates of patients who died
Number of subjects: 256
Study: 32940615

Group type: EXPERIMENTAL
Intervention: Therapist-guided, internet-delivered psychological intervention (9-step program focusing on stress, worry, and valued action)
Number of subjects: 7
Study: 36082508

Group type: EXPERIMENTAL
Intervention: NRPT 1X (recommended daily dose)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: NRPT 2X (double dose)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 34087229

Group type: EXPERIMENTAL
Intervention: VM hysteropexy
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Native tissue repair
Number of subjects: 94

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 94
Study: 35410939

Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive behavioural therapy (iCBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: online discussion forum (ODF)
Number of subjects: 0
Study: 34111898

Group type: EXPERIMENTAL
Intervention: Humanoid Robot
Number of subjects: 117

Group type: COMPARATOR
Intervention: Tablet Computer
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Both Robot and Tablet
Number of subjects: 117
Study: 36372250

Group type: EXPERIMENTAL
Intervention: Highly purified EPA (1800 mg/day)
Number of subjects: 2460

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2460

Group type: EXPERIMENTAL
Intervention: Observational part
Number of subjects: 2460
Study: 32912416

Group type: EXPERIMENTAL
Intervention: Combined catheterization group (TEG + POCUS)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Routine catheterization group
Number of subjects: 97
Study: 36343427

Group type: EXPERIMENTAL
Intervention: BI 1358894 (100 mg)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Citalopram (20 mg)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 34134450

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg/day
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg/day
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 33054248

Group type: EXPERIMENTAL
Intervention: High energy diet
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Medium energy diet
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Low energy diet
Number of subjects: 120
Study: 35315257

Group type: EXPERIMENTAL
Intervention: Esaxerenone 5-mg orally disintegrating tablet (ODT) taken with water
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Esaxerenone 5-mg orally disintegrating tablet (ODT) taken without water
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional oral tablet (5-mg)
Number of subjects: 0
Study: 32251766

Group type: EXPERIMENTAL
Intervention: Negative/low regulation temperament group
Number of subjects: 660

Group type: COMPARATOR
Intervention: Neutral/average regulation temperament group
Number of subjects: 660

Group type: COMPARATOR
Intervention: Positive/high regulation temperament group
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Overall dietary behavior
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Temperament interaction with intervention
Number of subjects: 660
Study: 36328115

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 1859

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1859
Study: 33180929

Group type: EXPERIMENTAL
Intervention: Vi‐tetanus toxoid conjugate (Vi‐TT) vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vi‐polysaccharide (Vi‐PS) vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vi‐TT and Vi‐PS vaccines (combined analysis)
Number of subjects: 0
Study: 32482617

Group type: EXPERIMENTAL
Intervention: Firehawk stent
Number of subjects: 1653

Group type: COMPARATOR
Intervention: XIENCE stent
Number of subjects: 1653
Study: 34506037

Group type: EXPERIMENTAL
Intervention: Prophylactic closed-incision negative pressure wound therapy dressing
Number of subjects: 1459

Group type: EXPERIMENTAL
Intervention: BMI ?40 kg/m2
Number of subjects: 1459

Group type: EXPERIMENTAL
Intervention: ?2 previous pregnancies
Number of subjects: 1459

Group type: EXPERIMENTAL
Intervention: Pre-CS vaginal cleansing
Number of subjects: 1459
Study: 34565428

Group type: EXPERIMENTAL
Intervention: Regular endoscopies
Number of subjects: 100

Group type: COMPARATOR
Intervention: Endoscopies at need
Number of subjects: 100

Group type: COMPARATOR
Intervention: NHS Digital data
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Trial-specific data
Number of subjects: 100
Study: 32059120

Group type: EXPERIMENTAL
Intervention: Immediate coronary angiogram (CAG)
Number of subjects: 970

Group type: COMPARATOR
Intervention: Delayed coronary angiogram (CAG)
Number of subjects: 970
Study: 35489376

Group type: EXPERIMENTAL
Intervention: NVX-CoV2373 vaccine (5 µg SARS-CoV-2 recombinant spike protein with 50 µg Matrix-M adjuvant)
Number of subjects: 4408

Group type: EXPERIMENTAL
Intervention: NVX-CoV2373 vaccine
Number of subjects: 4408

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 4408
Study: 33517233

Group type: EXPERIMENTAL
Intervention: Nicotine cigarettes (various contents: 1.3, 2.3, 5.5, 11.2, and 17.4 mg/g)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Menthol cigarettes (matched on nicotine)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Very Low Nicotine Content (VLNC) cigarettes (0.4 mg/g)
Number of subjects: 37
Study: 34255679

Group type: EXPERIMENTAL
Intervention: MY-RID intervention (smartphone-based messages delivered over 6 weeks)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: MY-RID intervention
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (attention control)
Number of subjects: 97
Study: 35388471

Group type: EXPERIMENTAL
Intervention: Nirmatrelvir/ritonavir (300/100 mg b.i.d.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nirmatrelvir/ritonavir (5-day regimen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33534381

Group type: EXPERIMENTAL
Intervention: OS eyes with glaucoma (OSWG)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: OS eyes without glaucoma (OSWOG)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy control eyes
Number of subjects: 26
Study: 33293038

Group type: EXPERIMENTAL
Intervention: Propofol-Ketamine (P-K)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dexmedetomidine-Ketamine (D-K)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 34530127

Group type: EXPERIMENTAL
Intervention: Minimally invasive distal pancreatectomy (MIDP)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Open distal pancreatectomy (ODP)
Number of subjects: 108
Study: 35940567

Group type: EXPERIMENTAL
Intervention: TDF/FTC plus HCQ
Number of subjects: 926

Group type: EXPERIMENTAL
Intervention: TDF/FTC plus HCQ placebo
Number of subjects: 926

Group type: EXPERIMENTAL
Intervention: HCQ plus TDF/FTC placebo
Number of subjects: 926

Group type: COMPARATOR
Intervention: TDF/FTC placebo plus HCQ placebo
Number of subjects: 926

Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 926
Study: 33651018

Group type: EXPERIMENTAL
Intervention: Surgical revision of secondary labial deformities
Number of subjects: 21
Study: 32554835

Group type: EXPERIMENTAL
Intervention: Traditional Persian medicine (TPM) strategies including exercise, nutrition, massage, bathing, aromatherapy, and sleeping.
Number of subjects: 0
Study: 34844107

Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Insulin (INS)
Number of subjects: 58
Study: 33931371

Group type: EXPERIMENTAL
Intervention: GnRHa trigger followed by a bolus of 1500 IU HCG s.c. on the oocyte retrieval day and 1000 IU HCG s.c. 4 days later, no vaginal LPS (Group A)
Number of subjects: 250

Group type: COMPARATOR
Intervention: 6500 IU HCG trigger followed by a standard vaginal progesterone LPS (Group B)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: GnRHa trigger followed by 1000 IU HCG s.c. on the oocyte retrieval day and 500 IU HCG s.c. 4 days later, no vaginal LPS (Group C)
Number of subjects: 250

Group type: COMPARATOR
Intervention: 6500 IU HCG trigger and a standard vaginal LPS (Group D)
Number of subjects: 250
Study: 32553329

Group type: EXPERIMENTAL
Intervention: Second-generation drug-eluting stents (DES)
Number of subjects: 19833

Group type: COMPARATOR
Intervention: First-generation drug-eluting stents (DES)
Number of subjects: 19833
Study: 35907864

Group type: EXPERIMENTAL
Intervention: Activity tracker intervention
Number of subjects: 1642

Group type: EXPERIMENTAL
Intervention: Activity tracker + digital motivational intervention
Number of subjects: 1642

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1642
Study: 33758058

Group type: EXPERIMENTAL
Intervention: Local anesthesia (eutectic mixture of lidocaine and prilocaine)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 32750393

Group type: EXPERIMENTAL
Intervention: 1-month dual anti-platelet therapy (DAPT) followed by 23-month ticagrelor monotherapy
Number of subjects: 3823

Group type: COMPARATOR
Intervention: 12-month dual anti-platelet therapy (DAPT) followed by 12-month aspirin monotherapy
Number of subjects: 3823
Study: 35822607

Group type: COMPARATOR
Intervention: LIA with ropivacaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: LIA with a new cocktail containing ropivacaine, diprospan, and morphine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 34294062

Group type: EXPERIMENTAL
Intervention: Reduced lung function (FEV1 and FVC)
Number of subjects: 132452

Group type: EXPERIMENTAL
Intervention: Increased liability to COPD
Number of subjects: 132452

Group type: EXPERIMENTAL
Intervention: Multivariable Mendelian randomization (MVMR) analysis
Number of subjects: 132452
Study: 36247856

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture combined with continuous attendance intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Routine attendance care
Number of subjects: 110
Study: 32349698

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Crisis Intervention (MBCI)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Social Activity Therapy (SAT)
Number of subjects: 50
Study: 34099629

Group type: EXPERIMENTAL
Intervention: Fat mass index, % fat mass, body mass index
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Fat-free mass index
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness
Number of subjects: 303
Study: 35977911

Group type: EXPERIMENTAL
Intervention: Beta-alanine supplementation (3.2 g/day for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Beta-alanine supplementation
Number of subjects: 40
Study: 35071424

Group type: EXPERIMENTAL
Intervention: C-arm navigation method (group A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional localization method (group B)
Number of subjects: 16
Study: 35219171

Group type: EXPERIMENTAL
Intervention: Exercise group (150 min/week of moderate-intense aerobic activity)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (standard medical care only)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study: 34816666

Group type: EXPERIMENTAL
Intervention: Tangeretin (200 mg/day)
Number of subjects: 24
Study: 32985283

Group type: EXPERIMENTAL
Intervention: Cat-keeping at home
Number of subjects: 11611

Group type: EXPERIMENTAL
Intervention: Poultry-keeping at home
Number of subjects: 11611

Group type: EXPERIMENTAL
Intervention: Sleeping with pets
Number of subjects: 11611
Study: 32066839

Group type: EXPERIMENTAL
Intervention: Follow-up cohort study
Number of subjects: 5072

Group type: EXPERIMENTAL
Intervention: Incidence of diabetes
Number of subjects: 5072

Group type: EXPERIMENTAL
Intervention: Incidence of known diabetes
Number of subjects: 5072
Study: 35456349

Group type: EXPERIMENTAL
Intervention: Common hepatic artery reconstruction
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non-reconstructed group
Number of subjects: 25
Study: 33213494

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHu‐EPO) 10000 IU subcutaneous injection after operation and once daily for the next week
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHu‐EPO)
Number of subjects: 152

Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 152
Study: 33808652

Group type: EXPERIMENTAL
Intervention: Vitamin K (400 µg MK‐7/day) and vitamin D3 (80 µg/day)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 35386097

Group type: EXPERIMENTAL
Intervention: Automated mechanical peripheral stimulation (AMPS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 28
Study: 33754184

Group type: EXPERIMENTAL
Intervention: Enteral resorbable diet (ED) with peristalsis-inhibiting medication
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard diet (SD)
Number of subjects: 66
Study: 33142437

Group type: EXPERIMENTAL
Intervention: Water pool (WP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lack of access to water pool (LWP)
Number of subjects: 120
Study: 33100212

Group type: EXPERIMENTAL
Intervention: Topical cream of Malva sylvestris extract, applied twice daily for 4 weeks.
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo cream, applied twice daily for 4 weeks.
Number of subjects: 51
Study: 32212024

Group type: EXPERIMENTAL
Intervention: 200 mmHg, 2 s compressive stimulus below heart level
Number of subjects: 12

Group type: COMPARATOR
Intervention: 200 mmHg, 2 s compressive stimulus above heart level
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Increasing pressure of compressive stimulus
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Increasing duration of compressive stimulus
Number of subjects: 12
Study: 35115097

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 4614

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 4614
Study: 34591022

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention delivered by peer educator
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention delivered by clinician
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Both interventions (peer and clinician)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Provider narrator
Number of subjects: 138
Study: 35346319

Group type: EXPERIMENTAL
Intervention: Awake prone positioning (APP)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 430
Study: 34002215

Group type: EXPERIMENTAL
Intervention: Stepwise layered provisional strategy
Number of subjects: 467

Group type: COMPARATOR
Intervention: Systematic dual stent approach
Number of subjects: 467
Study: 32783942

Group type: EXPERIMENTAL
Intervention: CRISPR-based multi-gene knockout screening system
Number of subjects: 0
Study: 33731145

Group type: EXPERIMENTAL
Intervention: Nutri-Score
Number of subjects: 3382

Group type: COMPARATOR
Intervention: Reference Intakes
Number of subjects: 3382

Group type: COMPARATOR
Intervention: No label
Number of subjects: 3382
Study: 32907575

Group type: EXPERIMENTAL
Intervention: Navafenterol 900 μg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Navafenterol 300 μg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Navafenterol (all doses)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Navafenterol
Number of subjects: 24
Study: 33188138

Group type: EXPERIMENTAL
Intervention: Intramuscular ceftriaxone followed by 5 days of azithromycin and metronidazole (IA)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Standard-of-care (SoC) of 14 days of ofloxacin and metronidazole
Number of subjects: 313
Study: 34047268

Group type: EXPERIMENTAL
Intervention: Maternal depressive symptoms
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Maternal vocabulary
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Indulgent feeding
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Breast‐feeding at 1 year
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Maternal education, BMI, occupation
Number of subjects: 405
Study: 32592694

Group type: EXPERIMENTAL
Intervention: Planned cesarean delivery
Number of subjects: 1393

Group type: COMPARATOR
Intervention: Planned vaginal delivery
Number of subjects: 1393
Study: 34932202

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 54
Study: 33957190

Group type: EXPERIMENTAL
Intervention: Oral Health Education Program combined with routine dental treatment (OHEPDT)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Dental treatment alone (DT)
Number of subjects: 295
Study: 32122717

Group type: EXPERIMENTAL
Intervention: Spinal immobilization at 0° angle (Group 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Spinal immobilization at 20° angle (Group 2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Comparison of ΔETCO2 levels between Groups 1 and 2
Number of subjects: 80
Study: 35181391

Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 0
Study: 33320198

Group type: EXPERIMENTAL
Intervention: Higher serum concentrations of metabolites of phosphate
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Higher serum concentrations of N-acetyl-d-glucosamine
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Higher serum concentrations of branched chained amino acids (BCAAs)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Higher serum concentrations of proline
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Higher serum concentrations of urea
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Higher serum concentrations of pyroglutamic acid
Number of subjects: 186

Group type: COMPARATOR
Intervention: 15 metabolites in women with fast decline (tertile 3)
Number of subjects: 186
Study: 33931498

Group type: EXPERIMENTAL
Intervention: Carboplatin (AUC 5), Paclitaxel (175 mg/m2), and Bevacizumab (15 mg/kg) for six 3-weekly cycles followed by Bevacizumab single agent (15 mg/kg) until progression or unacceptable toxicity
Number of subjects: 398
Study: 34154431

Group type: EXPERIMENTAL
Intervention: 4-month physical activity group program (two walks per week and a monthly visit to a sociocultural facility)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 150
Study: 35246243

Group type: EXPERIMENTAL
Intervention: Diacerein 50 mg once-daily (n=18)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (n=17)
Number of subjects: 25